R.S. IPRATROP 1.25 is a medication that combines Levosalbutamol and Ipratropium Bromide in a respiratory solution. It is used to treat lung diseases like asthma and chronic obstructive pulmonary disease (COPD).. This medication helps to alleviate symptoms like wheezing, shortness of breath, and coughing by dilating the airways and reducing inflammation.

The dosage of R.S. IPRATROP 1.25 varies depending on the individual's condition and response to treatment. It is typically administered through inhalation, as directed by a healthcare professional. Patients should follow the prescribed dosage regimen carefully and not exceed the recommended dose without consulting their doctor. 

 Like all medications, R.S. IPRATROP 1.25 may cause side effects in some individuals. Common side effects may include dry mouth, throat irritation, headache, dizziness, and palpitations. If any of these side effects persist or worsen, notify their healthcare provider promptly. In rare cases, severe allergic reactions breathing problems may occur, necessitating immediate medical attention. 

The cost of R.S. IPRATROP 1.25 can vary depending on factors such as the dosage strength, quantity, and location of purchase. Patients are advised to check with their local pharmacies or healthcare providers for specific pricing information and potential insurance coverage. 

 R.S. IPRATROP 1.25 contains two active ingredients: Levosalbutamol and Ipratropium Bromide. Levosalbutamol is a bronchodilator that works by relaxing the muscles in the airways, making breathing easier. Ipratropium Bromide is an anticholinergic agent that helps to reduce bronchospasm and mucus production in the lungs. 

 Patients should inform their healthcare provider about any pre-existing medical conditions, allergies, or medications they are taking before starting treatment with R.S. IPRATROP 1.25. It is essential to use this medication exactly as prescribed and to attend regular follow-up appointments to monitor treatment effectiveness and any potential side effects. Additionally, patients should store the medication at room temperature away from moisture and heat, and keep it out of reach of children. In summary, R.S. IPRATROP 1.25 is a respiratory solution containing Levosalbutamol and Ipratropium Bromide, used to manage conditions such as COPD and asthma. Patients should follow their healthcare provider's instructions carefully regarding dosage, potential side effects, and proper use of the medication. A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology. 

 EMAIL: info@sterispharma.com / contact@sterispharma.com 

 CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668